February 2019, Vol 9, No 2
By Chase Doyle
The economic burden caused by cancer and its treatment affects more than the patient’s bank account. As studies have shown, financial toxicity can lead to reduced quality of life, compromise treatment, and worsen clinical outcomes, and the associated devastation can extend to caregivers as well. Read Article ›
By Phoebe Starr
San Antonio, TX—An interim analysis of a randomized clinical trial showed that a lifestyle intervention aimed at weight loss achieved approximately a 1-kg weight loss in patients with early breast cancer who received chemotherapy, whereas patients in the control group gained approximately 1 kg over the course of the study. Read Article ›
The word on the street is that value-based, or risk-based, oncology contracts for physicians are the inevitable wave of the future. But are they? Read Article ›
Although many quality measures exist in oncology, few efforts have been undertaken to prioritize, measure, and report quality and costs for an entire region. A recent multiyear, multistakeholder effort to characterize quality of care and costs for Washington State oncology practices revealed that increased quality may be associated with a reduced cost of care in oncology. Read Article ›
Supervised Exercise During Chemotherapy Improves Cardiovascular Function in Women with Breast Cancer
By Phoebe Starr
A 12-month supervised exercise program improved cardiovascular function in women receiving adjuvant chemotherapy for breast cancer, including anthracyclines and taxanes. These results of a randomized clinical trial were presented at the 2018 San Antonio Breast Cancer Symposium. Read Article ›